1 Division of Otolaryngology-Head & Neck Surgery, University of British Columbia, Vancouver, British Columbia, Canada.
2 T. H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
Otolaryngol Head Neck Surg. 2018 Jun;158(6):1057-1064. doi: 10.1177/0194599818755353. Epub 2018 Feb 13.
Objectives There are well-established outcome disparities among different demographic groups with head and neck squamous cell carcinoma (HNSCC). We aimed to investigate the potential contribution of patient choice of nonsurgical treatment to these disparities by estimating the rate of this phenomenon, identifying its predictors, and estimating the effect on cancer-specific survival. Study Design Retrospective nationwide analysis. Settings Surveillance, Epidemiology, and End Results Database (2004-2014). Subjects and Methods Patients with HNSCC, who were recommended for primary surgery, were included. Multivariable logistic regression was used to identify demographic and clinical factors associated with patient choice of nonsurgical treatment, and Kaplan Meier/Cox regression was used to analyze survival. Results Of 114,506 patients with HNSCC, 58,816 (51.4%) were recommended for primary surgery, and of those, 1550 (2.7%) chose nonsurgical treatment. Those who chose nonsurgical treatment were more likely to be older (67.1 ± 12.6 vs 63.6 ± 13.1, P < .01), were of Black (odds ratio [OR], 1.49; 95% confidence interval [CI], 1.28-1.74) or Asian (OR = 1.79; 95% CI, 1.46-2.20) ethnicity, were unmarried (OR married, 0.50; 95% CI, 0.44-0.58), had an advanced tumor, and had a hypopharyngeal or laryngeal primary. Choice of nonsurgical treatment imparted a 2.16-fold (95% CI, 2.02-2.30) increased risk of cancer-specific death. Conclusion Of the patients, 2.7% chose nonsurgical treatment despite a provider recommendation that impairs survival. Choice of nonsurgical treatment is associated with older age, having Black or Asian ethnicity, being unmarried, having an advanced stage tumor, and having a primary site in the hypopharynx or larynx. Knowledge of these disparities may help providers counsel patients and help patients make informed decisions.
头颈部鳞状细胞癌(HNSCC)不同人群的预后存在明显差异。我们旨在通过评估这种现象的发生率、确定其预测因素并估计对癌症特异性生存的影响,来研究患者选择非手术治疗对这些差异的潜在贡献。
回顾性全国性分析。
监测、流行病学和最终结果数据库(2004-2014 年)。
纳入了被建议进行原发性手术治疗的 HNSCC 患者。采用多变量逻辑回归来确定与患者选择非手术治疗相关的人口统计学和临床因素,并采用 Kaplan-Meier/Cox 回归来分析生存情况。
在 114506 例 HNSCC 患者中,58816 例(51.4%)被建议进行原发性手术治疗,其中 1550 例(2.7%)选择了非手术治疗。选择非手术治疗的患者更有可能年龄较大(67.1±12.6 岁比 63.6±13.1 岁,P<.01),为黑种人(比值比[OR],1.49;95%置信区间[CI],1.28-1.74)或亚裔(OR=1.79;95%CI,1.46-2.20),未婚(OR 为 married,0.50;95%CI,0.44-0.58),肿瘤处于晚期,且原发部位为下咽或喉。选择非手术治疗使癌症特异性死亡的风险增加了 2.16 倍(95%CI,2.02-2.30)。
尽管有提供者建议,但仍有 2.7%的患者选择非手术治疗,这会损害生存。选择非手术治疗与年龄较大、黑种人或亚裔、未婚、肿瘤处于晚期以及原发部位在下咽或喉有关。了解这些差异可能有助于提供者为患者提供咨询,并帮助患者做出明智的决策。